Plant-Produced Recombinant Humaninterleukin-2
Print
EmailRecombinant human interleukin-2 (rhIL-2) is a biopharmaceutical protein of great importance, asit is the standard FDA-approved immunotherapeutic treatment for end-stage metastatic melanomaand renal cell cancer.
Find out more about this topic in this article.
Did you find this article useful?
You Might Also Be Interested In
-
CANR student Ashley Prince talks with the Class of 2021 about resilience, empowerment and growth.
Published on May 18, 2021
-
MSU awarded $500,000 USDA-NIFA grant to support food processing program
Published on June 11, 2020
-
Training future foresters new part of partnership between MSU, community colleges, industry
Published on September 24, 2020
-
A Message to 2021 CANR Graduates
Published on April 27, 2021
-
MSU faculty optimize remote field experiences for forestry students
Published on October 22, 2020
